Wsfs Capital Management »

Royalty Pharma shares owned by Wsfs Capital Management

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Wsfs Capital Management from 13F filings

Historical chart of Wsfs Capital Management investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Wsfs Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Wsfs Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $232k 9.1k 25.51
2024-09-30 $241k 8.5k 28.29

More positions owned by Wsfs Capital Management

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Microsoft Corporation (MSFT)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Alphabet Cap Stk Cl A (GOOGL)
Oracle Corporation (ORCL)
JPMorgan Chase & Co. (JPM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Merck & Co (MRK)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Cisco Systems (CSCO)

View all positions for Wsfs Capital Management

Top funds holding Royalty Pharma

Morgan Stanley
Vanguard Group
FMR
BlackRock
Adage Capital Partners GP
Baillie Gifford & Co
Viking Global Investors
Swedbank AB
State Street Corporation
Geode Capital Management
Norges Bank Investment Management
Two Sigma Advisers
Northern Trust
GMT Capital Corp
Deutsche Bank Aktiengesellschaft

View all funds holding Royalty Pharma